https://www.selleckchem.com/pr....oducts/bay80-6946.ht
Although D-dimer, sepsis physiology, and consumptive coagulopathy are indicators of mortality, current data do not suggest the use of full intensity anticoagulation doses unless otherwise clinically indicated. Even though there is an associated coagulopathy with COVID-19, bleeding manifestations, even in those with DIC, have not been reported. If bleeding does occur, standard guidelines for the management of DIC and bleeding should be followed. Copyright © 2020 American Society of Hematology.AIM Diabetes is a conventional risk factor
Like
Comment
Share
